Servier CDMO Expands Chromatography Platform in Normandy

Servier CDMO announces that the company has invested $7.5 million USD in intensified technology included continuous chromatography with simulated moving beds (SMB) and super critical fluid chromatography (SFC) with solvent recycling of up to 90% to lower environmental impact.

Servier CDMO expects at least a 50% increase in productivity with the existing configuration of the high-volume batch columns that are used to manufacture drug substances. The investment supports the chemical purification of 50kg (kilograms) per day, and the chiral separation of 10kg per day to support clinical trials and market supply upon drug approvals.

The highly qualified team at the Bolbec site, in Normandy, is composed of experts in chemical processes and is certified to handle highly potent compounds to occupational exposure band five (OEB 5). Bolbec is a fully United States Food & Drug Administration (FDA) current good manufacturing practice (cGMP) site for human pharmaceuticals.

Servier CDMO believes that this exceptional expertise and technology give pharmaceutical companies access to the means to accelerate the development and commercialization of novel therapies that will meet significant unmet patient needs for highly potent compounds.

Image: Industiral preparative chromatography platform at Bolbec, France (Source: Servier)